Industry: Pharma & Healthcare
Published Date: 2024-04-07
Pages: 90 Pages
Report ld: 2709288
Request Sample
Customized Report
Human Prothrombin Complex Market Size(US$)

CAGR 2024-2030
11.8%
Market Size,2030
USD 3,473.8
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
The global Human Prothrombin Complex market is projected to grow from US$ 1778.9 million in 2024 to US$ 3473.8 million by 2030, at a Compound Annual Growth Rate (CAGR) of 11.8% during the forecast period.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
Report Covers:
This report presents an overview of global market for Human Prothrombin Complex, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Human Prothrombin Complex, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Human Prothrombin Complex, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Prothrombin Complex sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Human Prothrombin Complex market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Human Prothrombin Complex sales, projected growth trends, production technology, application and end-user industry.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Human Prothrombin Complex in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Human Prothrombin Complex manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Prothrombin Complex sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Human Prothrombin Complex Product Introduction
1.2 Market by Type
1.2.1 Global Human Prothrombin Complex Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 500 IU/Vial
1.2.3 600 IU/Vial
1.2.4 1000 IU/Vial
1.2.5 Others
1.3 Market by Application
1.3.1 Global Human Prothrombin Complex Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hemophilia B
1.3.3 Vitamin K Deficiency
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Human Prothrombin Complex Sales Estimates and Forecasts 2019-2030
2.2 Global Human Prothrombin Complex Revenue by Region
2.2.1 Global Human Prothrombin Complex Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Human Prothrombin Complex Revenue by Region (2019-2024)
2.2.3 Global Human Prothrombin Complex Revenue by Region (2025-2030)
2.2.4 Global Human Prothrombin Complex Revenue Market Share by Region (2019-2030)
2.3 Global Human Prothrombin Complex Sales Estimates and Forecasts 2019-2030
2.4 Global Human Prothrombin Complex Sales by Region
2.4.1 Global Human Prothrombin Complex Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Human Prothrombin Complex Sales by Region (2019-2024)
2.4.3 Global Human Prothrombin Complex Sales by Region (2025-2030)
2.4.4 Global Human Prothrombin Complex Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Human Prothrombin Complex Sales by Manufacturers
3.1.1 Global Human Prothrombin Complex Sales by Manufacturers (2019-2024)
3.1.2 Global Human Prothrombin Complex Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Prothrombin Complex in 2023
3.2 Global Human Prothrombin Complex Revenue by Manufacturers
3.2.1 Global Human Prothrombin Complex Revenue by Manufacturers (2019-2024)
3.2.2 Global Human Prothrombin Complex Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Human Prothrombin Complex Revenue in 2023
3.3 Global Key Players of Human Prothrombin Complex, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Human Prothrombin Complex Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Human Prothrombin Complex, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Human Prothrombin Complex, Product Offered and Application
3.8 Global Key Manufacturers of Human Prothrombin Complex, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Prothrombin Complex Sales by Type
4.1.1 Global Human Prothrombin Complex Historical Sales by Type (2019-2024)
4.1.2 Global Human Prothrombin Complex Forecasted Sales by Type (2025-2030)
4.1.3 Global Human Prothrombin Complex Sales Market Share by Type (2019-2030)
4.2 Global Human Prothrombin Complex Revenue by Type
4.2.1 Global Human Prothrombin Complex Historical Revenue by Type (2019-2024)
4.2.2 Global Human Prothrombin Complex Forecasted Revenue by Type (2025-2030)
4.2.3 Global Human Prothrombin Complex Revenue Market Share by Type (2019-2030)
4.3 Global Human Prothrombin Complex Price by Type
4.3.1 Global Human Prothrombin Complex Price by Type (2019-2024)
4.3.2 Global Human Prothrombin Complex Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Human Prothrombin Complex Sales by Application
5.1.1 Global Human Prothrombin Complex Historical Sales by Application (2019-2024)
5.1.2 Global Human Prothrombin Complex Forecasted Sales by Application (2025-2030)
5.1.3 Global Human Prothrombin Complex Sales Market Share by Application (2019-2030)
5.2 Global Human Prothrombin Complex Revenue by Application
5.2.1 Global Human Prothrombin Complex Historical Revenue by Application (2019-2024)
5.2.2 Global Human Prothrombin Complex Forecasted Revenue by Application (2025-2030)
5.2.3 Global Human Prothrombin Complex Revenue Market Share by Application (2019-2030)
5.3 Global Human Prothrombin Complex Price by Application
5.3.1 Global Human Prothrombin Complex Price by Application (2019-2024)
5.3.2 Global Human Prothrombin Complex Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Human Prothrombin Complex Market Size by Type
6.1.1 US & Canada Human Prothrombin Complex Sales by Type (2019-2030)
6.1.2 US & Canada Human Prothrombin Complex Revenue by Type (2019-2030)
6.2 US & Canada Human Prothrombin Complex Market Size by Application
6.2.1 US & Canada Human Prothrombin Complex Sales by Application (2019-2030)
6.2.2 US & Canada Human Prothrombin Complex Revenue by Application (2019-2030)
6.3 US & Canada Human Prothrombin Complex Market Size by Country
6.3.1 US & Canada Human Prothrombin Complex Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Human Prothrombin Complex Sales by Country (2019-2030)
6.3.3 US & Canada Human Prothrombin Complex Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Human Prothrombin Complex Market Size by Type
7.1.1 Europe Human Prothrombin Complex Sales by Type (2019-2030)
7.1.2 Europe Human Prothrombin Complex Revenue by Type (2019-2030)
7.2 Europe Human Prothrombin Complex Market Size by Application
7.2.1 Europe Human Prothrombin Complex Sales by Application (2019-2030)
7.2.2 Europe Human Prothrombin Complex Revenue by Application (2019-2030)
7.3 Europe Human Prothrombin Complex Market Size by Country
7.3.1 Europe Human Prothrombin Complex Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Human Prothrombin Complex Sales by Country (2019-2030)
7.3.3 Europe Human Prothrombin Complex Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Human Prothrombin Complex Market Size
8.1.1 China Human Prothrombin Complex Sales (2019-2030)
8.1.2 China Human Prothrombin Complex Revenue (2019-2030)
8.2 China Human Prothrombin Complex Market Size by Application
8.2.1 China Human Prothrombin Complex Sales by Application (2019-2030)
8.2.2 China Human Prothrombin Complex Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Human Prothrombin Complex Market Size by Type
9.1.1 Asia Human Prothrombin Complex Sales by Type (2019-2030)
9.1.2 Asia Human Prothrombin Complex Revenue by Type (2019-2030)
9.2 Asia Human Prothrombin Complex Market Size by Application
9.2.1 Asia Human Prothrombin Complex Sales by Application (2019-2030)
9.2.2 Asia Human Prothrombin Complex Revenue by Application (2019-2030)
9.3 Asia Human Prothrombin Complex Sales by Region
9.3.1 Asia Human Prothrombin Complex Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Human Prothrombin Complex Revenue by Region (2019-2030)
9.3.3 Asia Human Prothrombin Complex Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Human Prothrombin Complex Market Size by Type
10.1.1 Middle East, Africa and Latin America Human Prothrombin Complex Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Human Prothrombin Complex Market Size by Application
10.2.1 Middle East, Africa and Latin America Human Prothrombin Complex Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Human Prothrombin Complex Sales by Country
10.3.1 Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Human Prothrombin Complex Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Human Prothrombin Complex Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Overview
11.1.3 Takeda Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Takeda Human Prothrombin Complex Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Takeda Recent Developments
11.2 CSL
11.2.1 CSL Company Information
11.2.2 CSL Overview
11.2.3 CSL Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 CSL Human Prothrombin Complex Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Recent Developments
11.3 Grifols
11.3.1 Grifols Company Information
11.3.2 Grifols Overview
11.3.3 Grifols Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Grifols Human Prothrombin Complex Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Grifols Recent Developments
11.4 Octapharma
11.4.1 Octapharma Company Information
11.4.2 Octapharma Overview
11.4.3 Octapharma Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Octapharma Human Prothrombin Complex Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Octapharma Recent Developments
11.5 Hualan Biological
11.5.1 Hualan Biological Company Information
11.5.2 Hualan Biological Overview
11.5.3 Hualan Biological Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Hualan Biological Human Prothrombin Complex Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Hualan Biological Recent Developments
11.6 Meheco Xinxing Pharma
11.6.1 Meheco Xinxing Pharma Company Information
11.6.2 Meheco Xinxing Pharma Overview
11.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Meheco Xinxing Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Prothrombin Complex Industry Chain Analysis
12.2 Human Prothrombin Complex Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Prothrombin Complex Production Mode & Process
12.4 Human Prothrombin Complex Sales and Marketing
12.4.1 Human Prothrombin Complex Sales Channels
12.4.2 Human Prothrombin Complex Distributors
12.5 Human Prothrombin Complex Customers
13 Market Dynamics
13.1 Human Prothrombin Complex Industry Trends
13.2 Human Prothrombin Complex Market Drivers
13.3 Human Prothrombin Complex Market Challenges
13.4 Human Prothrombin Complex Market Restraints
14 Key Findings in The Global Human Prothrombin Complex Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Human Prothrombin Complex market size was US$ 2177 million in 2025 and is forecast to reach a readjusted size of US$ 4702 million by 2032 with a CAGR of 11.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 80
USD 4250.00
(Single User License)
The global Human Prothrombin Complex market was valued at US$ 2177 million in 2025 and is anticipated to reach US$ 4702 million by 2032, at a CAGR of 11.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 117
USD 2900.00
(Single User License)
The global market for Human Prothrombin Complex was estimated to be worth US$ 2177 million in 2025 and is projected to reach US$ 4702 million, growing at a CAGR of 11.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 100
USD 3950.00
(Single User License)
The global Human Prothrombin Complex market is projected to grow from US$ 1968 million in 2024 to US$ 4251 million by 2031, at a CAGR of 11.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 146
USD 4900.00
(Single User License)
In 2024, the global market size of Human Prothrombin Complex was estimated to be worth US$ 1968 million and is forecast to reach approximately US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 139
USD 5900.00
(Single User License)
The global Human Prothrombin Complex market size was US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 80
USD 4250.00
(Single User License)
The global market for Human Prothrombin Complex was estimated to be worth US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 100
USD 3950.00
(Single User License)
The global market for Human Prothrombin Complex was valued at US$ 1968 million in the year 2024 and is projected to reach a revised size of US$ 4251 million by 2031, growing at a CAGR of 11.8% during the forecast period.
Published Date: 2025-01-16
Pages: 86
USD 2900.00
(Single User License)
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-17
Pages: 142
USD 5600.00
(Single User License)
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-16
Pages: 137
USD 5900.00
(Single User License)
The global Human Prothrombin Complex market size was US$ 2177 million in 2025 and is forecast to reach a readjusted size of US$ 4702 million by 2032 with a CAGR of 11.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 80
The global Human Prothrombin Complex market was valued at US$ 2177 million in 2025 and is anticipated to reach US$ 4702 million by 2032, at a CAGR of 11.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 117
The global market for Human Prothrombin Complex was estimated to be worth US$ 2177 million in 2025 and is projected to reach US$ 4702 million, growing at a CAGR of 11.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 100
The global Human Prothrombin Complex market is projected to grow from US$ 1968 million in 2024 to US$ 4251 million by 2031, at a CAGR of 11.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 146
In 2024, the global market size of Human Prothrombin Complex was estimated to be worth US$ 1968 million and is forecast to reach approximately US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 139
The global Human Prothrombin Complex market size was US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 80
The global market for Human Prothrombin Complex was estimated to be worth US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 100
The global market for Human Prothrombin Complex was valued at US$ 1968 million in the year 2024 and is projected to reach a revised size of US$ 4251 million by 2031, growing at a CAGR of 11.8% during the forecast period.
Published: 2025-01-16
Pages: 86
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-17
Pages: 142
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-16
Pages: 137
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now